Skip to main content
MOVE
NASDAQ Technology

Corvex Q2 2026: $12.8M Loss, Material Weakness, and $7.5M GPU Financing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$10.31
Mkt Cap
$323.891M
52W Low
$3.439
52W High
$26.72
52W Position info
200% above low
Off High info
61% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

MOVE has more than doubled off its 52-week low of $3.439.

Summary

Corvex reported Q2 2026 revenue of $3.8M and a net loss of $12.8M, disclosed a material weakness in internal controls, and secured $7.5M in GPU financing.


Key Events · Earnings and Guidance · MOVE

  • Q2 2026 Net Loss of $12.8M

    Revenue of $3.8M was offset by $19.0M in operating expenses, driven by $12.1M in general and administrative costs including $7.6M in stock-based compensation.

  • Material Weakness in Internal Controls

    Management concluded disclosure controls and procedures were not effective as of June 30, 2026, due to previously identified material weaknesses in the control environment, IT general controls, and process-level controls.

  • Legacy Assets Disposed to Settle Bridge Loan

    On June 30, 2026, the company transferred legacy healthcare assets to Evie Holdings, LLC in full satisfaction of the Bridge Loan, resulting in a $2.5 million gain.

  • $7.5M GPU Loan Agreement

    Subsequent to quarter end, Corvex Primus LLC entered into a secured equipment financing facility with GPU Finance Ltd., borrowing $7.5M at 10% interest to fund GPU server purchases.


Analysis · MOVE · Technology

The first full quarter as an AI cloud computing company reveals a $12.8 million net loss on $3.8 million revenue, with cash of $21.7 million. A material weakness in internal controls and a $7.5 million GPU equipment loan were also disclosed. The legacy healthcare business was disposed of to settle a bridge loan, resulting in a $2.5 million gain. These results and disclosures provide the first detailed look at the post-merger financial position.

At the time of this filing, MOVE was trading at $10.31 on NASDAQ in the Technology sector, with a market capitalization of approximately $323.9M. The 52-week trading range was $3.44 to $26.72. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MOVE - Latest Insights

MOVE
Aug 14, 2026, 4:20 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $11.83
Real-time Price: $11.44 info
Change: -$0.390 (-3%) info
Market Cap: $323.891M info
MOVE
Aug 04, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $21.13
Real-time Price: $11.44 info
Change: -$9.69 (-46%) info
Market Cap: $323.891M info
MOVE
Jul 10, 2026, 5:10 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $16.79
Real-time Price: $11.44 info
Change: -$5.35 (-32%) info
Market Cap: $323.891M info
MOVE
Jul 08, 2026, 8:13 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $16.54
Real-time Price: $11.44 info
Change: -$5.10 (-31%) info
Market Cap: $323.891M info
MOVE
Jul 08, 2026, 8:13 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $16.54
Real-time Price: $11.44 info
Change: -$5.10 (-31%) info
Market Cap: $323.891M info